Trichomonas vaginalis

Trichomonas vaginalis Overview

Trichomonas vaginalis is the most prevalent curable STI globally, associated with vaginitis, preterm birth, and increased HIV risk (Van Gerwen & Muzny, 2019). Its inclusion in STI panels ensures detection and simple, effective treatment with metronidazole (Workowski et al., 2021).

References

Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park I., Reno, H., Jonathan M. Zenilman J.M.,Bolan, G. A. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187. https://doi.org/10.15585/mmwr.rr7004a1

Products used to detect Trichomonas vaginalis

STI PCR Panel – Large

The STI large PCR panel is designed for multiplex in vitro assessment of 9 common microbiota typically associated with transmission by sexual activity, using real-time PCR.

Women’s Health PCR Panel – Large

The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.